#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adrenoleukodystrophy Plasma cell myeloma recurrent Nephrotic syndrome Ischaemic stroke Gastrooesophageal cancer Turner's syndrome Alagille syndrome Follicular lymphoma stage I Rhabdoid tumour Hyperinsulinism Autoimmune disorder Intracranial calcification Drug eruption Synovitis Brain injury More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis – Basic Information Primary hyperoxaluria – Life with Disease Pleural mesothelioma malignant – Trials in Disease Small intestine leiomyosarcoma – Life with Disease Myelodysplastic syndrome with excess blasts – Diagnostics Pulmonary sarcoidosis – Basic Information Epidermolysis bullosa Hyperoxaluria Congenital hypotransferrinaemia – Basic Information Leiomyosarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Metoprolol Succinate IMA401 Desoximetasone Nelarabine ORG-129 Art6043 Sodium Iodide SC0062 Sar-443579 Denosumab Alogliptin Amylase Argatroban Monohydrate Clemizole Hydrochloride Miransertib Octreotide Hydrochloride Tazemetostat Cx-037231 SIGVOTATUG VEDOTIN Idarubicin More therapies…

    Learn about Your Condition

    Myocarditis post infection Osteosarcoma recurrent Chronic hepatitis C Cardiac failure acute Pulmonary hypertension Eczema Anal cancer stage II Congenital pseudarthrosis Nocturia Injection site pain Hypoalbuminaemia Diffuse large B-cell lymphoma Biliary neoplasm Hyperparathyroidism secondary Renal cell carcinoma stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Sanatorium profesora Arenbergera

Sanatorium profesora Arenbergera

BOLZANOVA 7, Prague, 110 00, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Naporafenib and Trametinib Combination to Other Therapies for Patients with Previously Treated Unresectable or Metastatic NRAS Mutant Melanoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Dacarbazine
    • Dacarbazine Citrate
    • Doxycycline Monohydrate
    Belgium Czechia Denmark France Germany Italy +4

  • Study on the Effectiveness and Safety of ANB032, Betamethasone Dipropionate, and Hydrocortisone for Patients with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Anb032
    • Betamethasone Dipropionate
    • Hydrocortisone
    Czechia Poland

  • Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Deucravacitinib
    Czechia Finland France Germany Hungary Poland +2

  • Study of daxdilimab injection for adults with moderate to severe discoid lupus erythematosus

    Not recruiting

    2 1
    Investigated Diseases:
    • Chronic cutaneous lupus erythematosus
    Investigated Drugs:
    • Daxdilimab
    Bulgaria Czechia Denmark France Germany Greece +1

  • Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Amlitelimab
    • Pimecrolimus
    • Tacrolimus
    Bulgaria Czechia France Germany Italy Spain

  • Long-Term Study of Ritlecitinib Tosilate for Adults and Adolescents with Alopecia Areata

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Alopecia areata
    Czechia Germany Poland Spain

  • Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Amlitelimab
    • Pimecrolimus
    • Tacrolimus
    Bulgaria Czechia Denmark France Germany Greece +5

  • Study of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema

    Not recruiting

    3 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Upadacitinib
    Austria Belgium Bulgaria Croatia Czechia Denmark +9
Previous Page
1 2 3

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!